Hdl Handle:
http://hdl.handle.net/10147/114790
Title:
Nephrogenic systemic fibrosis.
Authors:
Kennedy, C; Magee, C; Eltayeb, E; Gulmann, C; Conlon, P J
Affiliation:
Department of Nephrology, Beaumont Hospital, Beaumont, Dublin 9. kennedyclaire@gmail.com
Citation:
Nephrogenic systemic fibrosis., 103 (7):208-10 Ir Med J
Journal:
Irish medical journal
Issue Date:
5-Nov-2010
URI:
http://hdl.handle.net/10147/114790
PubMed ID:
20845600
Abstract:
Nephroaenic systemic fibrosis (NSF) is a potentiallv fatal dermatiological condition found exclusively in patients with advanced renal I failure. There is minimal literature regarding the epidemiology and outcomes of patients with NSF in Ireland. A retrospective chart review was performed for all patients with NSF in Ireland. Ireland's experience with the disease was examined in light of international reports. There have been three cases of NSF in Ireland; an area which serves 1915 dialysis patients--giving a point prevalence among Irish end-stage kidney disease patients of 0.002. There was a large variation in disease severity between the three patients. All three patients had significant exposure to gadolinium chelate. Caution with gadolinium administration must be exercised in patients with advanced renal failure.
Item Type:
Article
Language:
en
MeSH:
Adult; Aged; Contrast Media; Female; Gadolinium DTPA; Humans; Ireland; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Peritoneal Dialysis
ISSN:
0332-3102

Full metadata record

DC FieldValue Language
dc.contributor.authorKennedy, Cen
dc.contributor.authorMagee, Cen
dc.contributor.authorEltayeb, Een
dc.contributor.authorGulmann, Cen
dc.contributor.authorConlon, P Jen
dc.date.accessioned2010-11-05T11:52:35Z-
dc.date.available2010-11-05T11:52:35Z-
dc.date.issued2010-11-05T11:52:35Z-
dc.identifier.citationNephrogenic systemic fibrosis., 103 (7):208-10 Ir Med Jen
dc.identifier.issn0332-3102-
dc.identifier.pmid20845600-
dc.identifier.urihttp://hdl.handle.net/10147/114790-
dc.description.abstractNephroaenic systemic fibrosis (NSF) is a potentiallv fatal dermatiological condition found exclusively in patients with advanced renal I failure. There is minimal literature regarding the epidemiology and outcomes of patients with NSF in Ireland. A retrospective chart review was performed for all patients with NSF in Ireland. Ireland's experience with the disease was examined in light of international reports. There have been three cases of NSF in Ireland; an area which serves 1915 dialysis patients--giving a point prevalence among Irish end-stage kidney disease patients of 0.002. There was a large variation in disease severity between the three patients. All three patients had significant exposure to gadolinium chelate. Caution with gadolinium administration must be exercised in patients with advanced renal failure.-
dc.language.isoenen
dc.subject.meshAdult-
dc.subject.meshAged-
dc.subject.meshContrast Media-
dc.subject.meshFemale-
dc.subject.meshGadolinium DTPA-
dc.subject.meshHumans-
dc.subject.meshIreland-
dc.subject.meshMale-
dc.subject.meshMiddle Aged-
dc.subject.meshNephrogenic Fibrosing Dermopathy-
dc.subject.meshPeritoneal Dialysis-
dc.titleNephrogenic systemic fibrosis.en
dc.typeArticleen
dc.contributor.departmentDepartment of Nephrology, Beaumont Hospital, Beaumont, Dublin 9. kennedyclaire@gmail.comen
dc.identifier.journalIrish medical journalen

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.